CD27 is a member of the tumor necrosis factor receptor superfamily. It is currently of interest to immunologists as a co-stimulatory immune checkpoint molecule, and is the target of an anti-cancer drug in clinical trials.

Expression

During mouse embryonic development, specific (medium) expression levels of CD27 (in addition to high cKit, medium Gata2,

3.Next